9
Participants
Start Date
July 7, 2021
Primary Completion Date
May 31, 2023
Study Completion Date
May 31, 2023
EDP-938
"EDP-938 800mg~Dose adjustments were made for subjects taking azole antifungals."
Placebo
Subjects took EDP-938 matching placebo tablets once a day orally for 21 days
Institute Jules Bordet, Anderlecht
FCRN Clinical Trial Centre (Pty) Ldt, Vereeniging
UZ Antwerpen, Edegem
Hôpital de Jolimont, La Louvière
Hospital de San Pedro de Alcantara, Cáceres
Hopital Cote de Nacre, Caen
Instituto Nacional de Cancerologia, Mexico City
Fundação PIO XII, Barretos
Hospital Universitario Virgen de Las Nieves, Granada
ASST degli Spedali Civili di Brescia - Spedali Civili di Brescia - INCIPIT - PIN, Brescia
Hospital Universitario Ramon y Cajal, Madrid
Hospital Universitario 12 de Octubre, Madrid
Hospital Universitario La Paz - PPDS, Madrid
A.O.U. Maggiore della Carità, Novara
Hospital Regional Universitario de Malaga - Hospital General, Málaga
Hospital General Universitario Morales Meseguer, Murcia
Hospital Universitario Virgen de La Arrixaca, El Palmar
Augusta University Medical Center, Augusta
Rambam Medical Center, Haifa
"Azienda ULSS 8 Berica - Ospedale San Bortolo", Vicenza
Hospital Universitario Virgen del Rocio - PPDS, Seville
Hospital Clinico Universitario de Valencia, Valencia
Hôtel Dieu -Angers, Angers
Changhua Christian Medical Foundation Changhua Christian Hospital, Changhua
Azienda Ospedaliera Universitaria Careggi, Florence
Sheba Medical Center, Ramat Gan
Hôpital Claude Huriez, Lille
Azienda Ospedaliero Universitaria Ospedali Riuniti di Ancona-Umberto I G.M. Lancisi G. Salesi, Ancona
Tel Aviv Sourasky Medical Center, Tel Aviv
Hôpital Saint Antoine, Paris
Hospital de Clinicas de Porto Alegre (HCPA) - PPDS, Porto Alegre
Hadassah Medical Center, Jerusalem
Gachon University Gil Medical Center, Ulsan
Fundación Favaloro, Buenos Aires
Instituto Fides, La Plata
Sanatorio Allende S.A., Córdoba
Hospital Britanico de Buenos Aires, Buenos Aires
Chronos Pesquisa Clínica, Brasília
Hospital Universitário de Santa Maria, Santa Maria
Hospital Alemão Oswaldo Cruz, São Paulo
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo
Toronto General Hospital, Toronto
Queen Mary Hospital, Hong Kong
Hospital Pablo Tobón Uribe, Medellín
Attikon University General Hospital, Athens
Evangelismos General Hospital of Athens, Athens
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy Oddzial w Gliwi, Gliwice
Uniwersyteckie Centrum Kliniczne, Gdansk
WITS Clinical Research Site, Johannesburg
Samsung Medical Center, Seoul
Taipei Veterans General Hospital, Taipei
Ege Universitesi Tip Fakultesi Hastanesi, Bornova
Namik Kemal University, Tekirdağ
Ondokuz Mayis Universitesi Tip Fakultesi Hastanesi, Samsun
CHU de Nice, Nice
Fondazione Policlinico Universitario A Gemelli, Roma
Albert Alberts Stem Cell Transplant Centre, Pretoria
Chungnam National University Hospital, Daejeon
Seoul National University Hospital, Seoul
The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul
Hospital Universitario Son Espases, Palma de Mallorca
ICO l'Hospitalet - Hospital Duran i Reynals, L'Hospitalet de Llobregat
Hospital Clinic de Barcelona, Barcelona
Imperial College, London
Lead Sponsor
Enanta Pharmaceuticals, Inc
INDUSTRY